Status:
COMPLETED
Horizontal Ridge Augmentation in Mandible Usign ROG + ESWT
Lead Sponsor:
Universidad El Bosque, Bogotá
Collaborating Sponsors:
Gloria Lafaurie
Carlos Leal
Conditions:
Bone Regeneration
Eligibility:
All Genders
35-65 years
Phase:
NA
Brief Summary
Guided bone regeneration (GBR) has been the most frequently used option to treat bone ridge deficiencies, allowing to restore such defects in order to place bone-integrated dental implants. A few repo...
Detailed Description
General Objective: Assessing the efficacy of horizontal augmentation and percentage of reabsorption of bone graft material in the technique of guided bone regeneration (GBR), combined with the shock ...
Eligibility Criteria
Inclusion
- Patients who agree to participate in the study and sign informed consent
- Partial mandibular edentulism requiring at least two teeth to be replaced with osseointegrated implants
- Patient with alveolar ridge thickness of ≤4mm, evaluated by CBCT
- Vertical bone availability of 9mm to anatomical structure such as a chin or dental canal that allows a short implant placement of 8mm at the end of the study.
- Extractions performed ≥ 6 months
- Elderly patients between 35 and 65 years old
- Patients without current disease or with chronic pathologies in medical control that does not affect the healing processes such as: controlled hypertension, controlled hypothyroidism, controlled hypercholesterolemia
- Evaluated by anamnesis and laboratory tests that rule out processes of immunosuppression, glycemia and coagulation disorders hypercholesterolemia
- No smoking
Exclusion
- Diabetes
- Immunosuppressive drugs
- Anti-coagulated or with dual anti-platelet aggregation
- Therapy with bisphosphonates
- Hormone replacement therapy
- Patient with a history of radiotherapy of the head and neck
- Pregnant women or nursing
- Permanent consumption of NSAIDs and corticosteroids
- Prolonged antibiotic therapy in the last 6 months
Key Trial Info
Start Date :
August 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2018
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT03785717
Start Date
August 1 2016
End Date
December 20 2018
Last Update
December 24 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yamil Lesmes
Bogotá, Colombia